Most drugs marketed or used as cognitive enhancers do not reliably make healthy people smarter by any objective measure. The research is surprisingly consistent on this point: when well-rested, well-nourished people take stimulants, nootropic supplements, or other so-called smart drugs and then sit down for cognitive testing, their scores generally stay flat or change in ways too small to matter. What does change, reliably, is how smart people feel. That gap between perceived enhancement and actual enhancement turns out to be the central story of cognitive pharmacology, and it has implications that go well beyond popping a pill before an exam.
What Stimulants Actually Do in a Healthy Brain
Prescription stimulants like methylphenidate (Ritalin, Concerta) and mixed amphetamine salts (Adderall) are the drugs most commonly associated with the “smart drug” idea, especially among college students. They work well for what they were designed to do: managing attention-deficit/hyperactivity disorder. But the leap from “helps people with ADHD focus” to “makes anyone smarter” doesn’t hold up when you test it.
A controlled study of methylphenidate in healthy young adults found no differences in performance on any cognitive test compared to placebo. What the drug did produce was a dose-dependent increase in self-reported wellbeing: people taking the higher dose felt better about how they were doing, even though they weren’t doing any better.1PubMed Central. Methylphenidate as a cognitive enhancer in healthy young people Mixed amphetamine salts tell a similar story. A study specifically designed to measure both objective and subjective enhancement found that the drugs did not improve cognitive abilities for participants in general. There was a hint that people who started with lower baseline ability showed small improvements on a few tasks, but the overwhelming finding was this: despite no measurable enhancement on most tasks for most people, participants believed the active drug was enhancing their cognition more than placebo.2Neuropharmacology. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people
This isn’t to say the drugs do nothing. They clearly increase arousal, alertness, and motivation. If you’re exhausted or bored, a stimulant can keep you grinding through material longer. But “able to sit still for six hours” and “smarter” are very different things, and the research draws a sharp line between them.
Why You Think It’s Working When It Isn’t
The illusion of enhancement isn’t just a quirk of stimulant studies. It appears to be a core feature of the entire smart-drug experience. Research on placebo responses in cognitive enhancement shows just how powerful expectation alone can be. In one experiment, participants who were told they received modafinil (but actually got a placebo nasal spray) rated their cognitive performance as significantly improved compared to a group told they received an antihistamine. The effect sizes were large: the placebo group felt substantially sharper and less tired, purely based on what they believed they had taken.3PubMed Central. Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
This matters because most people evaluate whether a drug “works” based on how they feel, not on test scores. If you take Adderall before studying and feel focused, confident, and productive, you’re going to conclude it made you smarter. You have no way to run your own controlled experiment. The drug did something real to your mood and arousal, and you attribute the feeling to cognitive improvement. A broad review of nootropic use in healthy individuals found that users generally perceive cognitive enhancers as effective, with enthusiastic anecdotal reports, even though their actual efficacy in healthy people is uncertain and any reported improvement temporary.4PubMed. Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
Modafinil and the Sleep-Deprivation Exception
Modafinil occupies a special place in the smart-drug world because it has the strongest evidence for cognitive effects in healthy people, but the picture is more complicated than the headlines suggest. A systematic review of modafinil studies in healthy, non-sleep-deprived subjects found that the drug appeared to enhance executive function and, on more complex tasks, improved attention and learning and memory. Simpler cognitive tests showed less consistent benefits, and creativity was largely unaffected.5European Neuropsychopharmacology. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review
Where modafinil really shines, though, is in sleep-deprived people, and this highlights an important distinction. A military review concluded that while modafinil’s trade-off between benefits and side effects has been deemed acceptable for sleep-deprived subjects, that reasoning should not be extended to well-rested individuals. The reviewers concluded against using modafinil as a cognitive enhancer outside sleep-deprivation scenarios.6Military Medicine. A State-of-the-Art Review on the Use of Modafinil as A Performance-enhancing Drug in the Context of Military Operationality In other words, modafinil can restore performance that sleep loss has degraded. That’s valuable in military and medical settings where people can’t sleep. But restoration isn’t the same as enhancement, and the distinction matters.
The Effort Trap
Perhaps the most counterintuitive finding in smart-drug research comes from a 2023 study that gave healthy participants methylphenidate, dextroamphetamine, or modafinil and then had them solve a complex optimization problem. The drugs made people work harder: they spent more time, took more steps, and appeared more motivated. But the quality of their solutions actually decreased compared to placebo. People on stimulants made more effort but produced worse outcomes. The researchers found that productivity differences across participants even reversed, meaning above-average performers ended up below average and vice versa, driven by increased randomness in how people approached the problem.7PubMed Central. Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort
This gets at something important about what “smart” actually means. Many cognitive tasks in real life aren’t about brute-force effort. They require strategic thinking, knowing when to stop exploring options, recognizing patterns efficiently. A drug that makes you more willing to grind through a problem but less able to think strategically about it could plausibly make you better at rote memorization while making you worse at the complex reasoning that matters more in professional and academic settings. The feeling of intense focus that stimulants produce can mask the fact that focus alone isn’t intelligence.
Why Brain Chemistry Makes This Personal
One reason smart-drug studies produce such inconsistent results is that the same drug can help one person and hurt another, depending on where their brain chemistry starts. This is best understood through the concept of an inverted-U relationship between dopamine activity in the prefrontal cortex and cognitive performance. A meta-analysis confirmed that working memory follows this curve: too little dopamine signaling in the prefrontal cortex impairs performance, optimal levels support it, and too much impairs it again.8PubMed Central. Quantifying the inverted U: A meta-analysis of prefrontal dopamine, D1-receptors, and working memory Animal research on individual neurons has confirmed the same pattern at the cellular level.9Nature Neuroscience. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
If your baseline dopamine signaling is already near the top of that curve (as it might be in a healthy, well-rested, low-stress young adult), adding a stimulant pushes you over the peak and down the other side. You don’t get smarter; you get worse. If your baseline is low, perhaps due to fatigue, stress, aging, or genetics, the same drug might push you closer to the optimum and genuinely help. This is why stimulants work well for ADHD (where baseline dopamine signaling is suboptimal) and poorly for people whose brains are already functioning well.
Genetics plays a concrete role here. The COMT gene, which codes for an enzyme that breaks down dopamine in the prefrontal cortex, comes in variants that process dopamine faster or slower. People with the higher-activity variant tend to have lower baseline cortical dopamine and may benefit more from stimulants, while those with the lower-activity variant may already be near the peak of the curve and actually deteriorate on the same drugs.10The Pharmacogenomics Journal. COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review A review of 25 studies on this pharmacogenetic interaction found mixed evidence for stimulants but strong evidence for antipsychotics. The COMT genotype remains one of the more promising markers for predicting who will actually respond to dopamine-boosting drugs.11Trends in Cognitive Sciences. Neurocognitive enhancement
The Modest Winners
Not everything in the nootropic world fails to deliver. A few substances show real, if modest, cognitive effects in controlled studies, and they tend to be the least exciting ones.
The combination of caffeine and L-theanine (an amino acid found in tea) has consistently performed well in cognitive testing. One study found that roughly 40 mg of caffeine combined with about 97 mg of L-theanine significantly improved accuracy during task-switching and increased self-reported alertness while reducing tiredness.12PubMed. The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness Another study confirmed improved attention-task performance when the two were combined.13The Journal of Nutrition. L-Theanine and Caffeine in Combination Affect Human Cognition as Evidenced by Oscillatory alpha-Band Activity and Attention Task Performance The effects are small, and nobody is going to ace a physics exam just because they drank tea, but the combination does appear to improve focused attention more reliably than caffeine alone.
Creatine, better known for its use in strength training, has emerging evidence as a cognitive supplement. The brain consumes enormous amounts of energy, and creatine helps regenerate the molecule that cells use as fuel. A meta-analysis found that creatine supplementation produced a small but significant reduction in the time required to complete attention tasks.14PubMed Central. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis Other cognitive measures like reaction time and word fluency showed more variable results.15PubMed Central. Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials The evidence is strongest for situations that tax brain energy, like sleep deprivation or demanding mental tasks, and may be more relevant for vegetarians and vegans, whose dietary creatine intake is lower.
Microdosing Psychedelics
Psilocybin microdosing has attracted intense interest as a potential creativity booster, but the controlled evidence is thin and mixed. A rapid review of placebo-controlled microdosing studies found that several failed to detect any effect on standard cognitive tests, creativity tasks, or suggestibility.16PubMed Central. Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research One double-blind study found that microdoses of dried psilocybin mushrooms produced noticeable subjective effects, but without evidence to support enhanced creativity, wellbeing, or cognitive function. In fact, a few small changes pointed toward cognitive impairment.17Translational Psychiatry. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
There is one intriguing exception. A pooled analysis of three double-blind trials found that active microdosing increased the originality of responses on a divergent thinking task, meaning people came up with more creative ideas relative to their total output. This effect held up even after controlling for dose-guessing and demographic biases. But the same study found no effects on other creativity measures or on convergent thinking, the kind of logical problem-solving most people mean when they talk about being “smart.”18PubMed. Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials The honest read of the microdosing literature is that expectation effects are powerful, objective effects are elusive, and if something real is there, it’s narrow and subtle.
Cholinergic Drugs and the Alzheimer’s Crossover
Donepezil (Aricept), used to treat Alzheimer’s disease by boosting acetylcholine levels in the brain, is one of the few drugs that has shown genuine cognitive improvements in healthy young people in controlled settings. One study found that a single dose improved sustained attention, reaction times, and dual-task performance, and the improvement on multitasking could not be explained by simple increases in alertness or arousal.19PubMed. Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning Another found it improved long-term recall of prose, object recall, and spatial memory.20PubMed. Acute cognitive effects of donepezil in young, healthy volunteers
Before anyone rushes to the pharmacy, these are single-dose studies in small groups. Nobody knows what happens when healthy people take donepezil long-term, the drug has real side effects (nausea, diarrhea, muscle cramps), and it was never designed or approved for cognitive enhancement in healthy individuals. But the fact that an acetylcholine-boosting drug can improve memory and multitasking in people who don’t have Alzheimer’s is scientifically interesting. It suggests that the cholinergic system has room for optimization in at least some healthy brains.
Racetams and the Supplement Problem
Piracetam, the original “nootropic” (the term was literally coined to describe it), belongs to a family of synthetic compounds called racetams. These have a devoted following online and a complicated legal status: piracetam is an authorized pharmaceutical in parts of Europe but not approved as a drug in the United States, where it exists in a regulatory grey zone alongside dozens of other compounds.21PubMed. Unauthorized ingredients in “nootropic” dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents
The evidence for racetams in healthy people is sparse. One study found that aniracetam could reverse cognitive deficits deliberately induced by a drug that blocks acetylcholine, suggesting real nootropic properties.22PubMed. The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers But reversing a drug-induced impairment is a far cry from enhancing a normally functioning brain. It’s the same restoration-versus-enhancement distinction that comes up with modafinil and sleep deprivation. Whether racetams do anything useful for someone who isn’t cognitively impaired remains genuinely uncertain.
The broader supplement market makes this worse. “Nootropic” dietary supplements often contain unauthorized ingredients, unapproved pharmaceuticals, and substances with significant regulatory variability across countries. What you buy online labeled as a nootropic stack might contain anything from tea extract to unregulated drugs, with no guarantee that the label matches the contents.
Long-Term Risks That Users Rarely Consider
Most conversations about smart drugs focus on whether they work, but there’s a separate question about what happens to the brain after extended use. Research on gene regulation in the brain’s reward and executive circuits has found that prolonged exposure to prescription stimulant “cognitive enhancers” can produce changes that are qualitatively similar to those seen with cocaine and other amphetamines. These neuronal changes may contribute to addiction liability.23PubMed Central. Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants This doesn’t mean that everyone who takes Adderall to study will develop an addiction. But it does mean that the brain’s response to chronic stimulant use isn’t fundamentally different just because the intent is academic rather than recreational.
There’s also the question of what happens to motivation and executive function when you remove a drug the brain has adapted to. If your prefrontal cortex adjusts its dopamine sensitivity downward in response to repeated stimulant exposure, you could end up with worse baseline cognitive function than you started with. This is well-documented in people who use stimulants recreationally, but systematic long-term studies in people using them purely for cognitive enhancement are scarce.
Who’s Using and Why
The pattern of stimulant misuse among students reveals something interesting about motivation. Research on college students found that GPA was inversely associated with intention to misuse stimulants: students with lower grades were more likely to consider using them. Academic stress, defined as worry about the impact of grades, wasn’t a reliable predictor on its own, but experiencing a real-time academic event (an upcoming exam, a paper deadline) in the moment was a medium-strength trigger for misuse intentions. Students who spent more time on campus were also more likely to consider misuse.24PubMed Central. Academic Factors Associated with College Students’ Prescription Stimulant Misuse in Daily Life: An Ecological Analysis of Multiple Levels
This suggests that stimulant use is less about trying to go from good to great and more about trying to cope with perceived academic failure or the anxiety of deadlines. It’s a coping mechanism dressed up as optimization. The irony, given the evidence above, is that these are exactly the students least likely to benefit from a drug whose main cognitive effect is making you feel like you’re performing better regardless of whether you are.
The Fairness Question Nobody Has Answered
Even if smart drugs worked perfectly, they’d raise uncomfortable questions. Cognitive enhancement use is more common in professions that demand sustained attention and focus, and among people trying to cope with sleep deprivation and increasing workloads.25PubMed Central. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions People with higher incomes and better healthcare access are more likely to obtain cognitive enhancers, creating the potential for an advantage in academic and professional settings that tracks existing inequality.26PubMed Central. Exploring Cognitive Enhancers: from neurotherapeutics to ethical and regulatory challenges: a mini review
The ethical debate has no clean resolution. Some argue that performance-enhancing drugs should be restricted because widespread use could pressure non-users into taking them just to stay competitive. Others take a libertarian view that individuals should have the right to decide whether the risks are worth it.27Frontiers in Psychiatry. Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges What makes the whole debate slightly absurd, at least for now, is that it’s largely hypothetical. We’re arguing about fairness over drugs that mostly don’t work as advertised. If a genuine cognitive enhancer ever emerged, one that reliably raised IQ or improved complex reasoning in healthy people, the ethical questions would become urgent. For the moment, they remain philosophical exercises about a product that doesn’t quite exist.